Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin
Lina Keutzer(Uppsala University), Ulrika S. H. Simonsson(Uppsala University), Ali Farnoud(Helmholtz Zentrum München), Gareth Maher‐Edwards(GlaxoSmithKline (United Kingdom)), Huifang You(Uppsala University), Michael P. Menden(Biotechnology Institute), Sebastian G. Wicha(Universität Hamburg), Georgios Vlasakakis(GlaxoSmithKline (United Kingdom)), Gita Khalili Moghaddam(GlaxoSmithKline (United Kingdom)), Joakim Nyberg(Uppsala University), Elin M. Svensson(Uppsala University)
Cited by 92
Related Papers
A Landscape of Pharmacogenomic Interactions in Cancer
|Cell|2016|2.3k
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
|Intensive Care Medicine|2020|1.1k
Machine Learning Prediction of Cancer Cell Sensitivity to Drugs Based on Genomic and Chemical Properties
|PLoS ONE|2013|567
Transcriptional data: a new gateway to drug repositioning?
|Drug Discovery Today|2012|248
PopED: An extended, parallelized, nonlinear mixed effects models optimal design tool
|Computer Methods and Programs in Biomedicine|2012|86